2[2]Bertolaccini ML, Atsumi T, Caliz AR, et al. Association of antiphosphatidylserine/prothrombin autoantibodies with HLA class Ⅱ genes. Arthritis Rheum, 2000, 43:683-688.
3[3]Pickering MC, Botto M, T. aylor PR, et al. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol, 2000, 76:227-324.
4[4]Sturfelt G, Bengtsson A, Klint C, et al. Novel roles of complement in systemic lupus erythernatosus-hypothesis for a pathogenetic vicious circle. J Rheumatol, 2000, 27:661-663.
5[5]Dijstelbloem HM, Bijl M, Fijnheer R, et al. Fc gamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum, 2000, 43:2793-2800.
6[6]Manger K, Repp R, Spriewald BW, et al. Fcr receptor II a polymorphism in Caucasian patients with systemic lupus erythematosus :association with clinical symptoms. Arthritis Rheum, 1998,41:1181-1189.
7[7]Lorenz HM, Herrmann M, Winkler T, et al. Role of apoptosis in autoimmunity. Apoptosis, 2000, 5:443-449.
8[8]Eskdale J, Keijsers V, Huizinga T, et al. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human inter[eukin-10(IL-10) locus. Genes Immun, 1999, 1:151-155.
9[9]Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA, 1998, 95:9465-9470.
10[10]Tsao BP, Cantor RM, Kalunian KC, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest, 1997, 99:725-731.
